Tranilast ameliorates impaired hepatic functions in Schistosoma mansoni-infected mice

Inflammopharmacology

Volumn 20, Issue 2, 2012, Pages 77-87

  Said, Eman ^a   Said, Shehta A ^a   Elkashef, Wagdi F ^b   Gameil, Nariman M ^a   Ammar, Elsayed M ^a  

^a MANSOURA UNIVERSITY   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

Liver; S. mansoni; Tranilast; Transforming growth 1

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; COLLAGEN; EOSIN; HEMATOXYLIN; HYDROXYPROLINE; PRAZIQUANTEL; TRANILAST; TRANSFORMING GROWTH FACTOR BETA1;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFIBROTIC ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; DRUG ACTIVITY; HISTOPATHOLOGY; IMMUNE RESPONSE; LIVER FIBROSIS; LIVER FUNCTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; TREATMENT OUTCOME;

ANIMALS; ANTHELMINTICS; ANTHRANILIC ACIDS; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; LIVER CIRRHOSIS; LIVER DISEASES, PARASITIC; LIVER FUNCTION TESTS; MALE; MICE; PRAZIQUANTEL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; TRANSFORMING GROWTH FACTOR BETA1; TREATMENT OUTCOME;

EID: 84863096590     PISSN: 09254692     EISSN: 15685608     Source Type: Journal    
DOI: 10.1007/s10787-011-0117-1     Document Type: Article

References (48)

1. Aiello LP, Bursell SE, Clermont A, Duh E, Ishii H, Takagi C, Mori F, Ciulia TA, Ways AK, Jirousek M, Smith LE, King GL (1997) Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes 46: 1473-1480.
2. Akahori H, Ota T, Torita M, Ando H, Kaneko S, Takamura T (2005) Tranilast prevents the progression of experimental diabetic nephropathy through suppression of enhanced extracellular matrix gene expression. J Pharmacol Exp Ther 314:514-521.
3. Ammar EM, Said SA, Eissa LA (2002) Mediation of the schistosomicidal effect of praziquantel through nitric oxide. Arzneim Forsch/Drug Res 11:844-848.
4. Andrade ZA (2009) Schistosomiasis and liver fibrosis. Parasite Immunol 31(11):656-663.
5. Bergman L, Loxley R (1963) Two improved and simplified methods for the spectrophotometric determination of hydroxyproline. Anal Chem 35:1961-1965.
6. Boloukhere M, Baldo-Correa E, Borojevic R (1993) Experimental schistosomiasis mansoni: characterization of connective tissue cells in hepatic periovular granulomas. J Submicroscop Cytol Pathol 25:505-517.
7. Boros DL (1989) Immunopathology of Schistosoma mansoni infection. Microbiol Rev 2:250-269.
8. Brito JM, Borojevic R (1997) Liver granulomas in schistosomiasis: mast cell-dependent induction of SCF expression in hepatic stellate cells is mediated by TNF-b. J Leukoc Biol 62:389-396.
9. Capper EA, Roshak A, Bolognese BJ, Podolin PL, Smith T, Dewitt DL, Anderson KM, Marshall LA (2000) Modulation of human monocyte activities by tranilast, SB 252218, a compound demonstrating efficacy in restenosis. J Pharmacol Exp Ther 295(3):1061-1069.
10. Chikaraishi A, Hirahashi J, Takase O, Marumo T, Hishikawa K, Hayashi M (2001) Tranilast inhibits interleukin-1b-induced monocyte chemoattractant protein-1 expression in rat mesangial cells. Eur J Pharmacol 427:151-158.
11. Cybulsky MI, Gimbrone MA Jr (1991) Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251:788-791.
12. Daniel WW (1991) Hypothesis testing. In: Biostatistics: a foundation for analysis in the health sciences, 5th edition. John Wiley & Sons, New York, pp 191-213.
13. Day TA, Bennett JL, Pax HA (1992) Praziquantel: the enigmatic antiparasitic. Parasiltol Today 8:342.
14. Derynck R (1994) Transforming growth factor-beta. In: homson AW (ed) The cytokine handbook. Academic Press, London, pp 319-342.
15. Fukuyama J, Miyazawa K, Hamano S, Ujiie A (1996) Inhibitory effects of tranilast on proliferation, migration, and collagen synthesis of human vascular smooth muscle cells. Can J Physiol Pharmacol 74:80-84.
16. Gonnert R, Andrews P (1977) Praziquantel, a new broad spectrum antischistosomal agent. Z parasitenkd 52(2):129-150.
17. Hessien MH, El-Sharkawi IM, El-Barbary AA, El-Beltagy DM, Snyder N (2010) Non-invasive index of liver fibrosis induced by alcohol, thioacetamide and schistosomal infection in mice. BMC Gastroenterol 10:53.
18. Ikeda H, Inao M, Fujiwara K (1996) Inhibitory effect of tranilast on activation and transforming growth factor-b1 expression in cultured rat stellate cells. Biochem Biophys Res Commun 227: 322-327.
19. Isaji M, Aruga N, Naito J, Miyata H (1994) Inhibition by tranilast of collagen accumulation in hypersensitive granulomatous inflammation in vivo and for morphological changes and functions of fibroblasts in vitro. Life Sci 55:287-292.
20. Isaji M, Miyata H, Ajisawa Y, Takehana Y, Yoshimura N (1997) Tranilast inhibits the proliferation, chemotaxis and tube formation of human microvascular endothelial cells in vitro and angiogenesis in vivo. Br J Pharmacol 122:1061-1066.
21. Isaji M, Miyata H, Ajisawa Y, Yoshimura N (1998) Inhibition by tranilast of vascular endothelial growth factor (VEGF)/vascular permeability factor (VPF)-induced increase in vascular permeability in rats. Life Sci 63:PL71-PL74.
22. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22:696-699.
23. Kawano Y, Noma T (1993) Cell action mechanism of tranilast- effect on the expression of HLA-class II antigen. Int J Immunopharmacol 15:487-500.
24. Komatsu H, Kojima M, Tsutsumi N, Hamano S, Kusama H, Ujiie A, Ikeda S, Nakazawa M (1988) Mechanism of inhibitory action of tranilast on the release of slow reacting substance of anaphylaxis (SRS-A) in vitro: effect of tranilast on the release of arachidonic acid and its metabolites. Jpn J Pharmacol 46:53-60.
25. Koyama S, Takagi H, Otani A, Suzuma K, Nishimura K, Honda Y (1999) Tranilast inhibits protein kinase C-dependent signalling pathway linked to angiogenic activities and gene expression of retinal microcapillary endothelial cells. Br J Pharmacol 127(2): 537-545.
26. Martin J, Kelly DJ, Mifsud SA, Zhang Y, Cox AJ, See F, Krum H, Wilkinson-Berka J, Gilbert RE (2005) Tranilast attenuates cardiac matrix deposition in experimental diabetes: role of transforming growth factor-b. Cardiovasc Res 65:694-701.
27. Matsumura T, Kugiyama K, Sugiyama S, Ota Y, Doi H, Ogata N, Oka H, Yasue H (1999) Suppression of atherosclerotic development in Watanabe heritable hyperlipidemic rabbits treated with an oral antiallergic drug, tranilast. Circulation 99:919-924.
28. Mifsud S, Kelly DJ, Qi W, Zhang Y, Pollock CA, Wilkinson-Berka JL, Gilbert RE (2003) Intervention with tranilast attenuates renal pathology and albuminuria in advanced experimental diabetic nephropathy. Nephron Physiol 95:83-91.
29. Miyajima A, Asano T, Yoshimura I, Seta K, Hayakawa M (2001) Tranilast ameliorates renal tubular damage in unilateral ureteral obstruction. J Urol 165:1714-1718.
30. Miyazawa K, Kikuchi S, Fukuyama J, Hamano S, Ujie A (1995) Inhibition of PDGF- and TGF-b1-induced collagen synthesis, migration and proliferation by tranilast in vascular smooth muscle cells from spontaneously hypertensive rats. Atherosclerosis 118:213-221.
31. Mori H, Tanaka H, Kawada K, Nagai H, Koda A (1995) Suppressive effects of tranilast on pulmonary fibrosis and activation of alveolar macrophages in mice treated with bleomycin: role of alveolar macrophages in the fibrosis. Jpn J Pharmacol 67:279-289.
32. Nishiyama A, Matsui M, Iwata S, Hirota K, Masutani H, Nakamura H, Takagi Y, Sono H, Gon Y, Yodoi J (1999) Identification of thioredoxin-binding protein-2/vitamin D3 up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J Biol Chem 274:21645-21650.
33. Pfab T, Hocher B (2004) Tranilast and hypertensive heart disease: further insights into mechanisms of an anti-inflammatory and anti-fibrotic drug. J Hyperten 22:883-886.
34. Platten M, Ho PP, Youssef S, Fontoura P, Garren H, Hur EM, Gupta R, Lee LY, Kidd BA, Robinson WH, Sobel RA, Selley ML, Steinman L (2005) Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite. Science 310:850-855.
35. Qi W, Chen X, Twigg S, Polhill TS, Gilbert RE, Pollock CA (2006) Tranilast attenuates connective tissue growth factor-induced extracellular matrix accumulation in renal cells. Kidney Int 69: 989-995.
36. Roberts AB, Sporn MB, Assosian RK, Smith JM, Roche NS, Wakefield LM, Hine UI, Liotta LA, Falanga V, Kehrl JH, Fanci AS (1986) Transforming growth factor typeb: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci 83:4167-4171.
37. Shimizu T, Kana KI, Kyo Y, Suzaki H, Asano K, Hisamitsu T (2006) Effect of tranilast on matrix metalloproteinase production from neutrophils in vitro. J Pharm Pharmacol 58(1):91-99.
38. Shiota N, Kovanen PT, Eklund KK, Shibata N, Shimoura K, Niibayashi T, Shimbori C, Okunishi H (2010) The anti-allergic compound tranilast attenuates inflammation and inhibits bone destruction in collagen-induced arthritis in mice. Br J Pharmacol 159(3):626-635.
39. Singh KP, Gerard HC, Hudson AP, Boros DL (2004) Dynamics of collagen, MMP and TIMP gene expression during the granulomatous, fibrotic process induced by Schistosoma mansoni eggs. Ann Trop Med Parasitol 98:581-593.
40. Soma J, Sugawara T, Huang YD, Nakajima J, Kawamura M (2002) Tranilast slows the progression of advanced diabetic nephropathy. Nephron 92:693-698.
41. Soomro NM, Arijo AG, Qureshi TA, Runham NW, Doenhoff MJ (2006) Effect of long term schistosomes infection on liver of the host. J Agr Soc Sci 3:219-222.
42. Springer TA (1990) Adhesion receptors of the immune system. Nature 346:425-434.
43. Suzawa H, Kikuchi S, Arai N, Koda A (1992a) The mechanism involved in the inhibitory action of tranilast on collagen biosynthesis of keloid fibroblasts. Jpn J Pharmacol 60:91-96.
44. Suzawa H, Kikuchi S, Ichikawa K (1992b) Inhibitory effect of an antiallergic drug, tranilast, on the production of cytokines. Pharmacometrics 43:409-414.
45. Tan SM, Zhang Y, Cox AJ, Kelly DJ, Qi W (2011) Tranilast attenuates the up-regulation of thioredoxin-interacting protein and oxidative stress in an experimental model of diabetic nephropathy. Nephrol Dial Transplant 26:100-110.
46. Vennervald B, Duanne D (2004) Morbidity in schistosomiasis: an update. Curr Opin Infect Dis 17:439-447.
47. Ward MR, Sasahara T, Agrotis A, Dilley RJ, Jennings GL, Bobik A (1998) Inhibitory effects of tranilast on expression of transforming growth factor-b isoforms and receptors in injured arteries. Atherosclerosis 137:267-275.
48. Yamada H, Tajima S, Nishikawa T, Murad S, Pinnell SR (1994) Tranilast, a selective inhibitor of collagen synthesis in human skin fibroblasts. J Biochem 116:892-897.